Paxlovid, the on-patent, antiviral drug Pfizer fast-tracked for COVID-19 early treatment after a year of insisting there was no reliable early treatment for COVID-19, has been getting some marketing attention recently.
A retired surgeon contracted COVID, but was prepared with his "Just-in-Case kit." He also tested ivermectin and Paxlovid on himself.
Paxlovid: A Guide to Making an Informed Decision - This Q&A from the Canadian COVID Care Alliance answers a number of targeted questions to better understand the oral antiviral medication currently being offered for COVID treatment.
This helpful infographic compares newly approved antiviral Paxlovid to ivermectin in regard to treating COVID-19.
In a new Op-ed in The Hill, Dr. Pierre Kory and Dr. Paul Marik call on health agencies to study the emerging diseases Long COVID and Long Vax.
An excerpt from 'The War on Ivermectin: The Medicine That Saved Millions and Could Have Ended the Pandemic', by Dr. Pierre Kory
Wednesday’s FLCCC Weekly Webinar was among the most important webinars we have ever presented. It marked the live introduction of Dr. Marik’s landmark Cancer Care monograph.
An FLCCC supporter, Charles K. Devitt, M.D., sent us this guest post outlining his thoughts on the recent, widely circulated article in The Atlantic proposing an amnesty over COVID matters.
Oh my…where to even begin? We know you are pressed for time, so we’re going to do our best here to highlight the key takeaways from one of the most astounding sociological studies to date on the impacts of censorship in the era of COVID. The study’s authors, academic professors and luminaries from Israel and Australia in [...]
It was a homecoming, of sorts. As the conference room doors swung open, there were hearty handshakes that fell into warm hugs. There were familiar names, new faces, exhilaration, relief, tears, joy — and overwhelming feelings of belonging.